These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 32561850

  • 1. The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis.
    Zhang X, Yang L, Szeto P, Abali GK, Zhang Y, Kulkarni A, Amarasinghe K, Li J, Vergara IA, Molania R, Papenfuss AT, McLean C, Shackleton M, Harvey KF.
    Oncogene; 2020 Jul; 39(30):5267-5281. PubMed ID: 32561850
    [Abstract] [Full Text] [Related]

  • 2. Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma.
    Zhang X, Tang JZ, Vergara IA, Zhang Y, Szeto P, Yang L, Mintoff C, Colebatch A, McIntosh L, Mitchell KA, Shaw E, Rizos H, Long GV, Hayward N, McArthur GA, Papenfuss AT, Harvey KF, Shackleton M.
    Mol Cancer Res; 2019 Jul; 17(7):1435-1449. PubMed ID: 30833299
    [Abstract] [Full Text] [Related]

  • 3. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
    Nallet-Staub F, Marsaud V, Li L, Gilbert C, Dodier S, Bataille V, Sudol M, Herlyn M, Mauviel A.
    J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K, Osada H, Murakami-Tonami Y, Horio Y, Hida T, Sekido Y.
    Cancer Lett; 2017 Jan 28; 385():215-224. PubMed ID: 27773750
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma.
    Zhou X, Chen N, Xu H, Zhou X, Wang J, Fang X, Zhang Y, Li Y, Yang J, Wang X.
    J Hematol Oncol; 2020 Jun 16; 13(1):77. PubMed ID: 32546241
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
    Chen D, Sun Y, Wei Y, Zhang P, Rezaeian AH, Teruya-Feldstein J, Gupta S, Liang H, Lin HK, Hung MC, Ma L.
    Nat Med; 2012 Oct 16; 18(10):1511-7. PubMed ID: 23001183
    [Abstract] [Full Text] [Related]

  • 13. The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.
    Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO.
    Proc Natl Acad Sci U S A; 2012 Sep 11; 109(37):E2441-50. PubMed ID: 22891335
    [Abstract] [Full Text] [Related]

  • 14. Bcl-2 dependent modulation of Hippo pathway in cancer cells.
    D'Aguanno S, Brignone M, Scalera S, Chiacchiarini M, Di Martile M, Valentini E, De Nicola F, Ricci A, Pelle F, Botti C, Maugeri-Saccà M, Del Bufalo D.
    Cell Commun Signal; 2024 May 16; 22(1):277. PubMed ID: 38755629
    [Abstract] [Full Text] [Related]

  • 15. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
    Zheng X, Chen L, Zhou Y, Wang Q, Zheng Z, Xu B, Wu C, Zhou Q, Hu W, Wu C, Jiang J.
    Mol Cancer; 2019 Mar 29; 18(1):47. PubMed ID: 30925892
    [Abstract] [Full Text] [Related]

  • 16. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW, Sridharan A, Xu Y, Stripp BR, Perl AK, Whitsett JA.
    J Mol Cell Biol; 2015 Feb 29; 7(1):35-47. PubMed ID: 25480985
    [Abstract] [Full Text] [Related]

  • 17. Genome-wide RNA interference screening reveals a COPI-MAP2K3 pathway required for YAP regulation.
    Kim YJ, Jung E, Shin E, Hong SH, Jeong HS, Hur G, Jeong HY, Lee SH, Lee JE, Kim GH, Kim J.
    Proc Natl Acad Sci U S A; 2020 Aug 18; 117(33):19994-20003. PubMed ID: 32747557
    [Abstract] [Full Text] [Related]

  • 18. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
    Janse van Rensburg HJ, Azad T, Ling M, Hao Y, Snetsinger B, Khanal P, Minassian LM, Graham CH, Rauh MJ, Yang X.
    Cancer Res; 2018 Mar 15; 78(6):1457-1470. PubMed ID: 29339539
    [Abstract] [Full Text] [Related]

  • 19. Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.
    Sharif GM, Schmidt MO, Yi C, Hu Z, Haddad BR, Glasgow E, Riegel AT, Wellstein A.
    Oncogene; 2015 Nov 26; 34(48):5879-89. PubMed ID: 25772246
    [Abstract] [Full Text] [Related]

  • 20. Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.
    Vargas RE, Duong VT, Han H, Ta AP, Chen Y, Zhao S, Yang B, Seo G, Chuc K, Oh S, El Ali A, Razorenova OV, Chen J, Luo R, Li X, Wang W.
    EMBO J; 2020 Jan 02; 39(1):e102406. PubMed ID: 31782549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.